- Turkish Journal of Veterinary and Animal Sciences
- Vol: 44 Issue: 3
- Assessment of mitogen-activated protein kinases as therapeutic targets for the treatment of babesios...
Assessment of mitogen-activated protein kinases as therapeutic targets for the treatment of babesiosis and theileriosis
Authors : Özal Mutlu
Pages : 702-713
Doi:10.3906/vet-2002-20
View : 8 | Download : 0
Publication Date : 9999-12-31
Article Type : Makaleler
Abstract :The Piroplasmida order comprises parasitic protozoa including the Theileria and Babesia species that are transmitted by vector ticks and can cause severe diseases in domestic and wild animals. Because of limited therapies and available drug resistance, the discovery of new, effective, and safer drugs for veterinary use is important. Mitogen-activated protein kinases MAPK are a group of serine-threonine protein kinases found in diverse species, including animals and protozoa that conduct vital cellular functions. Therefore, they have been at the centre of drug design studies for many years. Computer-aided structure-based drug design is a fast and effective way in drug discovery efforts to identify candidate compounds. In this study, we conducted comparative sequence analysis of MAPK proteins from the Theileria T. annulata, T. parva., T. orientalis, and T. equi and Babesia species B. bigemina, B. microti, and B. bovis . Three-dimensional protein structures from relevant species T. annulata and B. bovis were modelled and compounds were screened for interaction. Results showed that the inhibitors designed for human use could also be potent against Prioplasmida MAPKs. Furthermore, the structural differences between Prioplasmida and mammalian MAPKs could be a way for researchers to better instigate selective drug design.Keywords : Mitogen-activated protein kinase, computer-aided drug design, theileriosis, babesiosis